Sysmex launches HISCL™ platform, enabling faster, scalable Alzheimer's blood testing

▤ Summary

Sysmex has launched the HISCL automated immunoassay platform for Alzheimer’s blood biomarker testing. The system delivers results in 17 minutes from a standard blood draw and avoids lumbar puncture and PET-based workflows. Independent studies cited in the release show strong diagnostic performance for p-Tau217 and Aβ42/40 assays. The platform is now available for laboratory use in Europe, with CE-IVD-marked and RUO assay options. The launch targets hospitals, memory clinics, and labs that want faster and more scalable diagnostic workflows.

▦ Linked Companies